The Perception of Female Smokers with Fibromyalgia on the Effects of Smoking on Fibromyalgia Symptoms

Weingarten, Toby N.; Vincent, Ann; Luedtke, Connie A.; Beebe, Timothy J.; Welch, Tasha L.; Chong, Elisa Y.; Schroeder, Darrell R.; Warner, David O.

doi:10.1111/papr.12402

Cited by 9 publications

(8 citation statements)

References 26 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Based on findings from our study, it is unclear whether smoking results in cognitive impairment or whether people with cognitive impairment use nicotine to cope with perceived cognitive dysfunction. For instance, a study by Weingarten et al revealed that most smokers who had FM used smoking to cope with pain symptoms via distraction and relaxation, to lessen emotional distress resulting from pain-induced frustration or sadness, and as justification for resting during smoking breaks 37 . Thus, it would be useful for future studies to explore the utility of medications that help patients quit smoking to assess whether cognitive deficits improve after cessation of smoking.…”

Section: Discussionmentioning

confidence: 99%

Tobacco Use in Fibromyalgia Is Associated With Cognitive Dysfunction

Lin

D’Souza

et al. 2019

Mayo Clinic Proceedings: Innovations, Quality & Outcomes

Self Cite

View full text Add to dashboard Cite

Objective To evaluate the association between smoking and cognitive function in patients with fibromyalgia. Patients and Methods We surveyed 668 patients with fibromyalgia from May 1, 2012 through November 30, 2013 at a major tertiary referral center. Patients were categorized by smoking status. Primary outcome of interest was cognitive function (MASQ questionnaire), and secondary outcomes included fibromyalgia symptom severity (FIQ-R questionnaire), quality of life (SF-36 questionnaire), fatigue (MFI-20 questionnaire), sleep (MOS-sleep scale), anxiety (GAD-7 questionnaire), and depression (PHQ-9 questionnaire). Independent Students' t -tests and χ 2 tests were performed for continuous and categorical variables, respectively. Univariate regression analysis identified variables predictive of outcomes, adjusting for age, gender, body mass index, marital status, and educational level. Results Ninety-four (14.07%) patients self-identified as smokers. There was an association of lower education level, unmarried status, and younger age in smokers compared with nonsmokers. In the adjusted univariate regression analysis, fibromyalgia smokers reported greater perceived total cognitive dysfunction ( P =.009) and greater subscale scores of perceived difficulty in language ( P =.03), verbal memory ( P =.003), visual-spatial memory ( P =.02), and attention ( P =.04) compared with nonsmokers with fibromyalgia. For secondary outcomes, smokers with fibromyalgia reported greater severity of fibromyalgia-related symptoms ( P =.006), worse quality-of-life index in the mental component scale ( P =.02), greater sleep problems ( P =.01), and increased anxiety ( P =.001) compared with nonsmokers who had fibromyalgia. Conclusion In patients with fibromyalgia, smoking is a risk factor for cognitive dysfunction. Moreover, smokers with fibromyalgia were more likely to report increased severity of fibromyalgia symptoms, worse quality of life, more sleep problems, and increased anxiety compared with nonsmokers with fibromyalgia.

show abstract

Section: Discussionmentioning

confidence: 99%

Tobacco Use in Fibromyalgia Is Associated With Cognitive Dysfunction

Lin

D’Souza

et al. 2019

Mayo Clinic Proceedings: Innovations, Quality & Outcomes

Self Cite

View full text Add to dashboard Cite

show abstract

“…Epidemiologic studies found that cigarette smoking is inversely associated with the risk of developing PD [25], and it has been postulated that the ease of smoking cessation is an early prodromal marker linked to a reduction in nicotine rewarding mechanisms [26]. Cigarette smoking is known to be more prevalent in FM patients, as it is in our cohort; it is possible that nicotine helps patients cope with the disease symptoms [27,28].…”

Section: Discussionmentioning

confidence: 84%

Fibromyalgia-Like Syndrome Associated with Parkinson’s Disease—A Cohort Study

Abuhasira

Zlotnik

Horev

et al. 2019

JCM

View full text Add to dashboard Cite

Parkinson’s disease (PD) and fibromyalgia (FM) are two relatively common disorders that are considered distinct diagnoses. The aim of this study was to investigate the epidemiological characteristics of patients with both PD and FM, as well as their comorbidities and medication use. We performed a population-based retrospective cohort study in Israel from 2000 to 2015. We identified patients with PD according to a refined medication tracer algorithm and patients with FM according to their medical records. Using the algorithm, we identified 2606 patients diagnosed with PD, 60 of them (2.3%) were also diagnosed with FM. Most of the patients were females (88.3%) and the mean age of FM diagnosis was 63.95 ± 12.27 years. These patients had a higher prevalence of depression, anxiety, and dementia. Of the patients diagnosed with PD + FM, 46 (76.7%) were diagnosed with FM after the diagnosis of PD. Patients with PD + FM used analgesics of distinct kinds in higher rates, as well as more anti-PD medications. We suggest that patients with PD + FM represent a distinct subgroup with a fibromyalgia-like syndrome associated with Parkinson’s disease (FLISPAD). Their PD is more treatment resistant, and they take more medications, both analgesics and anti-PD.

show abstract

“…32 As with our study, this study of more than 400,000 veterans also found pain and symptom severity to be postively correlated to smoking status (current smoker, odds ratio [OR], 1.29) vs former smoker, OR, 1.02). 32 The association between chronic pain and smoking may reflect either the use of tobacco as a way to cope with pain, 12,33,34 continued smoking aggravating painful conditions, 33 or both. Smokers who are motivated to use tobacco to cope with or assuage pain may unwittingly aggravate their painful condition by increasing their cigarette consumption, thus entering into an endless cycle that could lead to greater nicotine dependence.…”

Section: Resultsmentioning

confidence: 99%

“…The association between chronic pain and smoking may reflect either the use of tobacco as a way to cope with pain, 12 , 33 , 34 continued smoking aggravating painful conditions, 33 or both. Smokers who are motivated to use tobacco to cope with or assuage pain may unwittingly aggravate their painful condition by increasing their cigarette consumption, thus entering into an endless cycle that could lead to greater nicotine dependence.…”

Section: Discussionmentioning

confidence: 99%

The Association of Current Tobacco Status With Pain and Symptom Severity in Fibromyalgia Patients

Croghan

Hurt

Ganesh

et al. 2021

Mayo Clinic Proceedings: Innovations, Quality & Outcomes

Self Cite

View full text Add to dashboard Cite

Objective: To describe current tobacco use among patients with newly confirmed fibromyalgia and evaluate the association between tobacco use status and severity of reported pain and other fibromyalgia symptoms.Patients and Methods: Participants in this study were adult patients (N¼1068) with fibromyalgia who met American College of Rheumatology 2010/2011 clinical criteria for fibromyalgia at the time of initial presentation to a Midwest fibromyalgia clinic (June 1, 2018, through May 31, 2019). Multiple linear regression analyses were performed to assess the association of tobacco use status with the Widespread Pain Index (WPI) and Symptom Severity Scale (SSS) scores. Covariates included in these analyses included age, sex, body mass index, depression, opioid medication use, and use of fibromyalgia-specific pharmacotherapy. Results: The patients were largely women (87.0%; n¼929), white (87.9%; n¼939), and with an average AE SD age of 46.6AE13.9 years. The WPI and SSS scores were significantly greater in current tobacco users compared with never tobacco users (WPI effect estimate [EE] ¼ 1.03; 95% CI, 0.30 to 1.76; type III P¼.020; SSS EE ¼ 0.47; 95% CI, 0.11 to 0.84; type III P¼.036). The WPI score was negatively associated with age (EE ¼ À0.02 per year; 95% CI, À0.03 to À0.001 per year; P¼.037) and no use of opioid medication (EE ¼ À1.08; 95% CI, À1.59 to À0.57; P<.001) while positively associated with higher body mass index (EE ¼ 0.03 per 1 kg/m 2 ; 95% CI, 0.001 to 0.06 per kg/m 2 ; P¼.04) and higher Patient Health Questionnaire-9 score (EE ¼ 0.12; 95% CI, 0.08 to 0.16; P<.001). Conclusion:The results of our study suggest that tobacco use is associated with greater pain and other symptom severity in patients with fibromyalgia. These findings have important clinical and research implications for patients with fibromyalgia who use tobacco and who may benefit from early identification and timely implementation of tobacco cessation treatment to decrease pain and improve overall quality of life.

show abstract

The Perception of Female Smokers with Fibromyalgia on the Effects of Smoking on Fibromyalgia Symptoms

Abstract: Smokers with fibromyalgia reported smoking helped to cope with fibromyalgia pain but generally did not directly ameliorate fibromyalgia physical symptoms.

Cited by 9 publications

References 26 publications

Tobacco Use in Fibromyalgia Is Associated With Cognitive Dysfunction

Tobacco Use in Fibromyalgia Is Associated With Cognitive Dysfunction

Fibromyalgia-Like Syndrome Associated with Parkinson’s Disease—A Cohort Study

The Association of Current Tobacco Status With Pain and Symptom Severity in Fibromyalgia Patients

Contact Info

Product

Resources

About